# Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock

> **NCT03014063** · — · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 18 (actual)

## Conditions studied

- Septic Shock

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03014063
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03014063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03014063, "Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03014063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*